Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease
Clinical trial NCT04617860 · TERMINATED
Trial details
- NCT number
- NCT04617860
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2021-04-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.